Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer? Journal Article

  

Author:	Azzoli, C. G.
Article Title:	Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?
Keywords:	survival; cancer survival; middle aged; survival rate; clinical trial; constipation; fatigue; neutropenia; cancer recurrence; angiogenesis inhibitor; cisplatin; drug efficacy; drug safety; antineoplastic agents; paclitaxel; cancer adjuvant therapy; postoperative care; chemotherapy, adjuvant; cancer staging; drug megadose; follow up; neoplasm staging; anorexia; carboplatin; sensory neuropathy; etoposide; lung non small cell cancer; lung resection; nausea; vomiting; antineoplastic combined chemotherapy protocols; carcinoma, non-small-cell lung; lung neoplasms; vinblastine; febrile neutropenia; drug fatality; ondansetron; vindesine; short survey; randomization; corticosteroid; navelbine; non-small-cell lung cancer; epidermal growth factor receptor kinase inhibitor; vinorelbine
Journal Title:	Nature Clinical Practice Oncology
Volume:	2
Issue:	11
ISSN:	1743-4254
Publisher:	Nature Publishing Group
Date Published:	2005-11-01
Start Page:	552
End Page:	553
Language:	English
DOI:	10.1038/ncponc0350
PUBMED:	16270095
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-28444435199&partnerID=40&md5=20b27f403f60106f80c6273ddd7827f0
Notes:	--- - "Cited By (since 1996): 3" - "Export Date: 24 October 2012" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/34675